
Melissa Burgess
@melissa8burgess
Sarcoma Med Onc @ Pitt, UPMC Hillman Cancer Center, Interested in Immunotherapy, Rare Tumors, Merkel Cell Carcinoma, Tweets are my own
ID: 871019464619413504
03-06-2017 15:03:17
523 Tweet
1,1K Followers
924 Following



Looking forward to the second CTOS #webinar co-chaired by #sarcoma experts Dario Callegaro and Thierry Alcindor, MD, MSc! Join us on April 26 for educational content and lively discussions on the diagnosis & management of Alveolar Soft Part Sarcoma (#ASPS). Register here: ctos.org/Meeting/CTOS20ā¦



Great presentation by Ben Nacev, MD PhD ASCO "Meet the Professors" on identifying genetic alterations in #sarcoma tumors to better diagnose and treat patients. UPMC UPMC Physician Resources Pitt Health Sciences Pittsburgh Cure Sarcoma



Trial Activation: EA7211/STRASS 2, led by Ken Cardona and Richard Riedel, is a randomized phase III study of neoadjuvant #chemotherapy followed by surgery versus surgery alone for patients w/ high risk retroperitoneal #sarcoma. For more info: bit.ly/EA7211



Great session on new clinical trials on systemic agents for patient with advanced #chordoma at Chordoma Foundation chaired by Christopher Heery MD Anthony P Conley Josh Sommer CTOS



An honor to attend the Chordoma Foundation international research workshop in Boston. Excited to see new advances and looking forward to new collaborations and friendship Christine K Lee




Congrats to Dr. Chen, @NCIResearchCtr , and all of the collaborators involved with this study. 1st IO indication in #sarcoma #asps Brian Van Tine Richard Riedel Melissa Burgess Elad Sharon and so many others MD Anderson Cancer Center


Great event! Thanks again TGCT Support and Sydney Stern, PhD, MS for the invitation! #tgct #pvns

#Sarcoma #EHE the trial is now out in Clinical Cancer Research aacrjournals.org/clincancerres/ā¦
